Product Information

CEPHALEXIN 750 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $4.9762 per EA under NDC 67877025523. Its NADAC has been published 332 times since Jan 22, 2014.

FDA first approved this application on Dec 20, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Cephalexin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for CEPHALEXIN 750 MG CAPSULE has been published 332 times since Jan 22, 2014, and over the history we have for it it has declined 17.2%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.